Heart Failure Policy Network seeks information on multidisciplinary and integrated care

News & Events

19 February 2018
AUTHOR: Web Admin HFPN

HFPN has launched a call for information on multidisciplinary and integrated heart failure care.

HFPN is seeking information from a range of stakeholders in heart failure, on how they have initiated and implemented a transition to a multidisciplinary and integrated model of care. We would particularly like to hear from patient advocates, healthcare professionals, professional societies and academics, among others.

Our aim in this work is to better understand the challenges of implementing multidisciplinary care in heart failure. We hope that real-world examples of the barriers and success factors in establishing such care models can be used to help others implement multidisciplinary and integrated care in their own settings.

Our mission in 2018 is to showcase proven, high-quality and sustainable models of care, and make the case for change to policymakers. Multidisciplinary care in heart failure is crucial European and national guidelines, but implementation is suboptimal and varies widely across Europe, which means many patients are not getting the care and support they need.

HFPN aims to use the information collected from stakeholders, supported by research, to produce a handbook on multidisciplinary and integrated heart failure care in May 2018.

The call for information will be open until 30 March 2018.

Tagged:

More from News & Events

Strategic consensus on heart failure in Portugal launched
Strategic consensus on heart failure in Portugal launched...
06 October 2020
The HFPN has collaborated with the Institute of Health Sciences of the Catholic University of Portugal to develop a strategic consensus on heart failure in Portugal....
Read article
HFPN participates in Portuguese event on heart failure
HFPN participates in Portuguese event on heart failure...
24 January 2020
The HFPN attended the Annual Meeting of the Heart Failure Working Group of the Portuguese Society of Cardiology....
Read article
The Heart Failure Policy Network is made possible with financial support from Novartis Pharma, AstraZeneca and Vifor Pharma. The content produced by the Network is non-promotional and not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members.